Authors
Latest:
eBook: The vital role of QC testingIn this eBook, Symbiosis explores the necessity to offer chemistry, non-sterile microbiology and sterile microbiology testing and the requirements for parenteral preparations.
Latest:
Fill/Finish Lessons Learned from COVID-19Can CDMOs apply lessons learned from the COVID-19 pandemic to improve sterile processing?
Latest:
New Developments in Plasma ProteomicsA single protein or gene expression product can exist in multiple proteoforms due to alternative splicing, point mutations, post translational modifications and endogenous proteolysis.
Latest:
Commercial Production of Gene Therapies Using Suspension or Adherent Cell LinesThis article will explore the traditional path from the laboratory to the clinic and how the fixed-bed technology provides an alternative solution to meet commercial demands.
Latest:
A Unified Approach for Scaling Bioprocess Unit OperationsA unified scale-up approach, as presented here, can be applied to any unit operation.
Latest:
Achieving High Productivities through Bioreactor Optimization at Lower than Peak Cell Densities in a Perfusion ProcessWebinar Date/Time: Wed, Dec 4, 2024 11:00 AM EST
Latest:
Innovations and Trends in Aseptic Manufacturing ProcessesThe steady rise in popularity of gene therapies and other biologics is the underlying reason for the growing importance of aseptic manufacturing processes in the biopharmaceutical industry.
Latest:
CPHI Frankfurt: Selecting the Right Outsourcing Strategy and PartnerSponsors should explore key considerations ahead of choosing a new outsourcing partner.
Latest:
Evaluating CMO/CDMO End-to-End Expertise: The Importance of Standardizing Cold ChainConversations with CMOs/CDMOs about capabilities and how they work to reduce complexities in the supply chain should focus on cost efficiency, temperature excursions, and sustainability.
Latest:
Purification Strategies to Process 5 g/L Titers of Monoclonal AntibodiesAltering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.
Latest:
Simulations Improve Production CapacityAs biotechnology organizations have successfully launched new products, the challenges of producing adequate quantities have grown. Many companies are now dealing with multiproduct manufacturing facilities and pushing the limits of their capabilities. One result of this complexity is a loss of production capacity due to inefficiencies.
Latest:
Funding Biodefense Vaccine DevelopmentBiodefense start-up companies have an abundance of options when seeking funding.
Latest:
The Development and Application of a Monoclonal Antibody Purification PlatformA purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Latest:
Upcoming Technologies to Facilitate More Efficient Biologics ManufacturingChoosing the right tools to enhance the process.
Latest:
Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and ExcipientsCan increase in ionic strength result in higher viscosity?
Latest:
Connecting the Manufacturing Process to Patient WellnessManufacturers of biopharmaceuticals can improve productivity by taking patient wellness into account.
Latest:
Disposable Bioreactors for Cells and MicrobesProductivities similar to those achieved with stirred tanks can be achieved with disposable bioreactors.
Latest:
Improving Tangential Flow Filtration YieldBest methods to maximize product yield and membrane lifetime to enhance a tangential flow filtration process.
Latest:
Disposable Bioreactors for Cells and MicrobesProductivities similar to those achieved with stirred tanks can be achieved with disposable bioreactors.
Latest:
Purification Strategies to Process 5 g/L Titers of Monoclonal AntibodiesAltering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.
Latest:
A Case Study of Developing Analytical MethodsContract manufacturers must plan for increased analytical resources in development and quality control.
Latest:
Increasing Efficiency in Protein and Cell Production by Combining Single-Use Bioreactor Technology and PerfusionAn off-the-shelf, single-use perfusion system.
Latest:
Purification Strategies to Process 5 g/L Titers of Monoclonal AntibodiesAltering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.
